Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -52.26%125.59K | -78.81%109.01K | -84.01%139.12K | -50.59%1.91M | -66.89%278.9K | -75.72%263.06K | -39.83%514.38K | -20.20%869.88K | 9.56%3.87M | -37.41%842.43K |
| Selling and administrative expenses | -33.78%114.32K | -48.55%147.84K | -80.07%135.77K | -49.51%1.4M | -39.53%346.29K | -77.56%172.65K | -55.35%287.36K | -9.82%681.32K | 7.71%2.77M | -42.11%572.64K |
| -Selling and marketing expense | --0 | --0 | --0 | -82.90%30.73K | --0 | --0 | -91.10%1.2K | 144.04%29.53K | 51.05%179.68K | 29.30%40.78K |
| -General and administrative expense | -33.78%114.32K | -48.34%147.84K | -79.17%135.77K | -47.19%1.37M | -34.89%346.29K | -73.68%172.65K | -54.58%286.17K | -12.32%651.79K | 5.61%2.59M | -44.46%531.86K |
| Research and development costs | --0 | -124.49%-40.67K | -98.13%3.35K | -54.35%498.75K | -57.31%113.9K | -82.83%53.49K | -8.85%166.09K | -46.16%178.75K | 16.63%1.09M | -19.01%266.82K |
| Other operating expenses | -69.48%11.27K | -96.98%1.84K | ---- | 51.36%16.8K | -6,201.85%-181.29K | 1,221.33%36.92K | 109.55%60.92K | 274.48%9.82K | -59.31%11.1K | --2.97K |
| Operating profit | 52.26%-125.59K | 78.81%-109.01K | 84.01%-139.12K | 50.59%-1.91M | 66.89%-278.9K | 75.72%-263.06K | 39.83%-514.38K | 20.20%-869.88K | -9.56%-3.87M | 37.41%-842.43K |
| Net non-operating interest income (expenses) | -1.03K | -1.01K | -800 | -196.60%-20K | -920.41%-20K | 0 | 0 | 0 | -17.47%-6.74K | -135.58%-1.96K |
| Non-operating interest expense | --1.03K | --1.01K | --800 | 196.60%20K | 920.41%20K | --0 | --0 | --0 | 17.47%6.74K | 135.58%1.96K |
| Other net income (expenses) | 221.02%40.73K | -157.86%-17.19K | 139.87%17.55K | 5,916.63%238.95K | 142.71%244.76K | 55.38%-33.65K | 174.96%29.7K | -536.24%-44.03K | -101.85%-4.11K | 6,917.54%100.84K |
| Gain on sale of security | 160.40%20.33K | -227.00%-37.72K | -47.74%-2.75K | 132.59%26.84K | 44.46%32.65K | 55.38%-33.65K | 174.96%29.7K | -118.43%-1.86K | -7,332.40%-82.35K | 1,472.65%22.6K |
| Special income (charges) | --0 | --0 | --0 | ---55.65K | ---55.65K | --0 | --0 | ---55.65K | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --55.65K | ---- | ---- | ---- | --55.65K | ---- | ---- |
| Other non-operating income (expenses) | --20.4K | --20.54K | 50.61%20.3K | 242.21%267.76K | ---- | ---- | ---- | --13.48K | 444.94%78.24K | ---- |
| Income before tax | 71.05%-85.9K | 73.76%-127.2K | 86.61%-122.37K | 56.37%-1.69M | 92.72%-54.14K | 74.44%-296.71K | 45.91%-484.68K | 15.50%-913.91K | -17.04%-3.88M | 44.73%-743.55K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 71.05%-85.9K | 73.76%-127.2K | 86.61%-122.37K | 56.37%-1.69M | 92.72%-54.14K | 74.44%-296.71K | 45.91%-484.68K | 15.50%-913.91K | -17.04%-3.88M | 44.73%-743.55K |
| Net income continuous operations | 71.05%-85.9K | 73.76%-127.2K | 86.61%-122.37K | 56.37%-1.69M | 92.72%-54.14K | 74.44%-296.71K | 45.91%-484.68K | 15.50%-913.91K | -17.04%-3.88M | 44.73%-743.55K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 71.05%-85.9K | 73.76%-127.2K | 86.61%-122.37K | 56.36%-1.69M | 92.63%-54.78K | 74.44%-296.71K | 45.91%-484.68K | 15.50%-913.91K | -17.03%-3.88M | 44.75%-743.28K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 71.05%-85.9K | 73.76%-127.2K | 86.61%-122.37K | 56.36%-1.69M | 92.63%-54.78K | 74.44%-296.71K | 45.91%-484.68K | 15.50%-913.91K | -17.03%-3.88M | 44.75%-743.28K |
| Diluted earnings per share | 0 | 73.74%-0.0007 | 86.74%-0.0006 | 66.67%-0.01 | 80.00%-0.002 | 80.00%-0.002 | 75.17%-0.0025 | 52.73%-0.0047 | -50.00%-0.03 | 0.00%-0.01 |
| Basic earnings per share | 0 | 73.74%-0.0007 | 86.74%-0.0006 | 66.67%-0.01 | 80.00%-0.002 | 80.00%-0.002 | 75.17%-0.0025 | 52.73%-0.0047 | -50.00%-0.03 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.